NEW YORK and TORONTO, Jan. 31, 2019 /CNW/ - iAnthus
Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE: IAN, OTCQX: ITHUF) and MPX Bioceutical Corporation
("MPX") (CSE: MPX; OTC: MPXEF) jointly announce that the previously announced plan of arrangement (the "Arrangement")
under the Business Corporations Act (British Columbia) pursuant to which iAnthus will
acquire all of the issued and outstanding common shares of MPX pursuant to the terms of an Arrangement Agreement between iAnthus
and MPX dated October 18, 2018 (the "Arrangement Agreement") is now expected to close on or
before February 5, 2019. Both parties and their respective advisors are working in
close collaboration to ensure the imminent closing of the transaction
Further information about the closing of the Arrangement is available on the SEDAR profiles of iAnthus and MPX at www.sedar.com.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary
facilities throughout the United States, providing investors diversified exposure to the U.S.
regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate
finance, law and health care services, iAnthus provides a unique combination of capital and hands-on operating and management
expertise. The Company uses these skills to support operations across six states. For more information, visit www.iAnthusCapital.com.
About MPX Bioceutical Corporation
MPX, through its wholly-owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory,
financial, real estate rental, logistics and administrative services to three medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts
(high-margin concentrates wholesale) brands. The successful Health for Life brand operates in the rapidly growing Phoenix
Metropolitan Statistical Area. With the acquisition of The Holistic Center, MPX added another operating medical cannabis
enterprise to its footprint in Arizona.
GreenMart of Nevada NLV, LLC ("GreenMart NV") is an award-winning licensed cultivation, production and wholesale
business, licensed for both the medical and "adult use" sectors in Las Vegas, Nevada, and is
already selling wholesale into the Nevada medical cannabis market. GreenMart NV has also
optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses
in the Las Vegas market which will operate under the "Health for Life" brand.
In Massachusetts, MPX is building out and will operate a cultivation and production facility
as well as up to three dispensaries and manages three full service dispensaries and one producer in Maryland.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning
the specific factors disclosed here and elsewhere in iAnthus' and MPX's periodic filings with Canadian securities regulators.
When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should, our
vision" and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, anticipated benefits associated with the acquisition of MPX and
the anticipated closing date of the transaction.
Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are
made as of the date of this release. iAnthus and MPX disclaim any intention or obligation to update or revise such information,
except as required by applicable law, and iAnthus and MPX do not assume any liability for disclosure relating to any other
company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news
release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in
the United States. The securities have not been and will not be registered under the United
States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered
or sold within the United States or to U.S. Persons unless registered under the U.S. Securities
Act and applicable state securities laws or an exemption from such registration is available.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ianthus-and-mpx-bioceutical-provide-update-to-business-combination-300787977.html
SOURCE iAnthus Capital Holdings, Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/31/c7837.html